ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas

Press/Media

Period	7 May 2025

Media coverage

Title	ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas
Media name/outlet	BioSpace
Country/Territory	United States
Date	7/05/25
URL	ct.moreover.com/?a=56675796392&p=1gw&v=1&x=Vy2w1BTeecArf2UEpvEaEA
Persons	Stephen Badylak